COSMOS Logo

Characterising risk and biology Of Smouldering Myeloma for early detection Of Symptomatic myeloma

WHAT is COSMOS

COSMOS is an observational study which means that there is no drug being tested. You will continue to be followed up regularly by your haematologist in clinic as normal. When you have a blood test or bone marrow test, we will use part of the sample for the study.

If you agree to take part in the study, you will have some extra investigations performed based on the risk of your condition developing into myeloma.

To find out a bit more about our study please take a look at our Youtube videos:


The COSMOS Team

Professor Kwee Yong

Professor Kwee Yong
Professor Kwee Yong is the Chief Investigator of the COSMOS study. She is the group leader of the multiple myeloma research lab at UCL and a consultant haematologist at University College Hospital (UCLH) where she runs the smouldering myeloma clinic

Professor Karthik Ramasamy

Professor Karthik Ramasamy
Dr Karthik Ramasamy is the co-Chief Investigator of the COSMOS study. He is a consultant haematologist in Oxford treating myeloma patients and Director of the Oxford Myeloma Translational Research Centre.

Dr Grant D. Vallance

Dr Grant D. Vallance
Dr Grant Vallance is based in Oxford as an information manager and teaches on the design and implementation of clinical trials at the University of Oxford. He is the data manager for the COSMOS study.

Dr Lydia Lee

Dr Lydia Lee
Dr Lydia Lee works at UCL investigating immune dysfunction in myeloma disease progression and is a consultant haematologist at UCLH, treating myeloma patients in clinic.

Dr Eileen Boyle

Dr Eileen Boyle
Dr Eileen Boyle is a Wellcome Trust clinician scientist at UCL investigating the role of immune dysfunction in shaping premalignant conditions and the role of aneuploidy in disease progression. She also sees patients in the UCLH smouldering myeloma clinic.

Dr Elise Rees

Dr Elise Rees
Dr Elise Rees is a postdoctoral scientist working in the UCL myeloma lab. She is studying the role of NK cells in the immune system in smouldering myeloma.

Jess Kimber

Jess Kimber
Jess Kimber is the COSMOS laboratory technician at UCL. responsible for the patient samples that are collected as part of the study.

Dr Dan Hughes

Dr Dan Hughes
Dr Dan Hughes is a clinical research fellow at UCL studying the consequences of chromosome loss in myeloma. He also sees patients in the UCLH smouldering myeloma clinic including those on COSMOS.

Dr Louise Ainley

Dr Louise Ainley
Dr Louise Ainley is a clinical research fellow at UCL studying the immune system in smouldering myeloma. She also sees patients in the UCLH smouldering myeloma clinic.

Rebecca Allen

Rebecca Allen
Rebekah Allen is a laboratory technician at UCL studying the role of NK cells in the immune system as well as processing patient samples from the COSMOS study in the UCL lab.

To find out more about smouldering myeloma see either of these sites:





For more information please contact the COSMOS team: cosmos@ucl.ac.uk


Cancer Research UK logoMyeloma Research Alliance logoNCRI logoUCL logo


Database & Website by Abapere IT Oxford LTD | gdvallance@abapere.com

Logo design by George Fisher | georgefisherdesign@outlook.com